Updated on 29 October 2015
The mission of Clinical Diabetes is to provide primary care providers and all clinicians involved in the care of people with diabetes with information on advances and state-of-the-art care for people with diabetes. Clinical Diabetes is also a forum for discussing diabetes-related problems in practice, medical-legal issues, case studies, digests of recent research, and patient education materials. All submissions to Clinical Diabetes will be reviewed by the editorial team and considered for publication if they contain information that would be helpful to the journal's readership. All articles, whether invited or submitted, should be written with general practice, family practice, or internal medicine providers in mind as the main audience
HOW CAN I SUBMIT AN ARTICLE TO THE JOURNAL?
Manuscripts may be submitted via http://mc.manuscriptcentral.com/clinical-diabetes. Before submitting an article, please review the information below and click on the appropriate link for further instructions related to the content and format of the article you wish to submit. All authors should complete, sign, and return the manuscript submission form before or soon after submitting their article. Once you have submitted your manuscript, the review process generally takes 4–6 weeks. Failure to follow the manuscript preparation and submission instructions may delay the review process.
Feature articles present either original research or reviews of topics related to diabetes in primary practice. Examples of feature articles can be found in any issue on the journal website.
Standing departments in each issue of Clinical Diabetes include:
- Guest Editorials
- Translating Research to Practice
- Practical Pointers
- Case Studies
- Bridges to Excellence
Click here for detailed instructions for writing these various types of articles.
EDITORIAL OFFICE CONTACT INFORMATION
ADA's Publications Policy Committee follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics. The policies for Clinical Diabetes have been adopted from those three advisory bodies and, where necessary, modified and tailored to meet the specific content, audiences, and aims of Clinical Diabetes. Comprehensive information related to the editorial and ethical policies of Clinical Diabetes can be found in Publication Policies and Procedures for ADA Journals. The Association's Publications Policy Committee or Subcommittee on Ethical Scientific Publications will consider on a case-by-case basis policies that are not addressed in the policies document, which contains information related to the following topics:
- Study Design
- Originality and Prior Publication
- Authorship and Contributions
- Conflict of Interest
- Clinical Trials, Systematic Reviews, and Meta-Analyses
- Digital Image Manipulation
- Responses to Possible Scientific Misconduct
- Peer Review
- Editorial Decisions
- Prepublication of Accepted Articles
- Reuse, Post-Prints, and Public Access
- Media Embargoes
Post-Prints and Public Access
Authors are permitted to submit the final, accepted version of their manuscript to their funding body or institution for inclusion in their funding body or institution's database, archive, or repository, or to post the final, accepted version on their personal website. These manuscripts may be made freely accessible to the public upon acceptance if certain conditions are observed. For details, please refer to the section on Copyright, Reuse, and Public Access in Publication Policies and Procedures for ADA Journals.
As a courtesy to authors, the final print versions of articles will be deposited in PubMed Central (PMC). In compliance with National Institutes of Health policy, these articles will appear on PMC 12 months after print publication in Clinical Diabetes and will be indexed on PubMed/Medline.
Currently all articles are freely accessible on Clinical Diabetes online (clinical.diabetesjournals.org). Effective 2016, full-text HTML content will become freely accessible 6 months after the print publication date, and PDF content will become freely accessible 12 months after the print publication date.